The American Academy of Pediatrics and the National Institute of Allergy and Infectious Disease issued new clinical guidelines for pediatricians around the introduction of peanut products in infant’s diets as a means of preventing peanut allergy. The new guidelines present an immediate clinical challenge for pediatricians to assess risk by identifying infants with severe eczema and/or egg allergy and subsequently test, refer, and/or counsel caregivers. Clinical decision support (CDS) integrated within electronic health record systems is an evidenced-based approach to facilitate adherence to clinical guidelines. Using a pediatrician informed approach, our group developed such a CDS tool called Intervention to Reduce Early Peanut Allergy in Children (iREACH). The primary aim of this study is to assess the efficacy of the iREACH intervention in increasing pediatrician adherence to the PPA guidelines via a practice-based cluster-randomized controlled trial.
|Effective start/end date||7/24/19 → 6/30/24|
- Ann & Robert H. Lurie Children's Hospital of Chicago (A19-0148-S001//5U01AI138907-02)
- National Institute of Allergy and Infectious Diseases (A19-0148-S001//5U01AI138907-02)